Phreesia, Inc.

Phreesia provides healthcare software and technology solutions designed to facilitate patient access, manage payments, and improve health outcomes. Its platform offers tools for patient self-scheduling, appointment management, digital intake, clinical data capture, patient communications, and analytics. It also provides payment processing, healthcare payment cards, and patient financing solutions, alongside a network engagement channel for life sciences companies. The company generates revenue across three primary areas: subscription and related services, payment solutions, and network solutions. Phreesia serves ambulatory practices, health systems, hospitals, life sciences businesses, government agencies, and not-for-profit organizations.

The company operates as a fully remote organization without principal executive offices, maintaining its corporate mailing address in Wilmington, Delaware. Its platform facilitated approximately 180 million patient visits in fiscal year 2026, accounting for roughly one in six ambulatory visits in the United States. As of January 31, 2026, Phreesia employs 1,789 full-time workers, comprising 756 employees located in the United States and 1,033 employees based internationally.

Summary of the business section of Phreesia's latest annual report, written by StockData.

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

“As of January 31, 2026, we had 1,789 full-time employees, including 502 in sales and marketing, 542 in research and development, 551 in services and support and 194 in general and administrative.”